Tambocor®
Back to Test Catalogue
Flecainide, Serum/Plasma
Test ID: FLECA S
Test
Aliases/Synonyms
Method
Chromatography/Mass Spectrometry
Report Includes
Flecainide
Specimens
Avoid gel separator tubes; Serum; Plasma (EDTA)
Clinical Utility
Monitoring the Flecainide concentration is used to assure compliance and avoid toxicity of this cardiac drug used to treat ventricular tachycardia and premature contractions.
Test Version
8-Sep-2023
Specimen
Specimens
Avoid gel separator tubes; Serum; Plasma (EDTA)
Sample Volume
2.0 mL
Minimum Volume
0.5 mL
Specimen Comment
Avoid gel separator tubes.
Collection & Handling
Collection Instructions
Collect trough specimen within 1 hour prior to next dose.
Handling Information
Store and send frozen.
Stability
| Ambient | 5 days |
|---|---|
| Refrigerated | 7 days |
| Frozen | 30 days |
Rejection Criteria
| Specimen | Gel-separator tube |
|---|---|
| Hemolysis | Gross |
| Lipemia | Present |
Test Version
8-Sep-2023
Performance / Interpretation
Method
Chromatography/Mass Spectrometry
Turnaround Time
11 days
Results
| Name | Units | Reference Range | Conversion Factor | |
|---|---|---|---|---|
| Flecainide | mcg/mL |
|
||
Test Version
8-Sep-2023
Interface / Setup
HL7 Interface Codes
| Order Code | Result Codes | Units |
|---|---|---|
| FLECA S | 63100FLECAINIDE | mcg/mL |
Test Version
8-Sep-2023